Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TD0101 |
AQC
6-Aminoquinolyl-N-hydroxysccinimidyl carbamate |
Others | Others |
AQC (6-Aminoquinolyl-N-hydroxysccinimidyl carbamate) 是一种高效液相色谱荧光检测氨基酸或蛋白质序列的试剂。它能够与一级和二级氨基酸反应生成荧光衍生物,在皮摩尔水平下能够检测氨基酸。 | |||
T11689 |
ITI-214
ITI214 |
PDE | Metabolism |
ITI-214 是一种中枢神经系统活性抑制剂,具有口服生物活性的PDE1抑制剂 (Kiof 58 pM),对其他 PDE 家族成员和一系列酶、受体、转运体和离子通道具有良好的选择性,在各种运动和认知功能的动物模型中显示出有效性。 | |||
T6748 |
A-1155463
A 1155463,A1155463,醋酸艾塞那肽 |
BCL | Apoptosis |
A-1155463是一种高效选择性的BCL-XL 抑制剂,对 BCL-XL 具有皮摩尔的结合亲和力,在Molt-4细胞中的EC50值为70 nM。 | |||
T4260 |
Capmatinib 2HCl
INC-280 2HCl,INCB28060盐酸盐,INCB28060 2HCl |
c-Met/HGFR | Tyrosine Kinase/Adaptors |
Capmatinib 2HCl (INC-280 2HCl) 是一种新型的 ATP 竞争性 c-MET 激酶抑制剂,IC50 为 0.13 nM。它具有皮摩尔酶效,对 c-MET 具有高度特异性,选择性超过 10, 000 倍一大组人类激酶。该抑制剂在 c-MET 依赖性肿瘤细胞系中有效阻断 c-MET 磷酸化和其关键下游效应子的激活。因此,它在体外有效抑制 c-MET 依赖性肿瘤细胞增殖和迁移,并有效诱导细胞凋亡。 | |||
T27161 |
DH376
DH-376,DH 376 |
||
DH376 inhibits DAGLα in a time and dose dependent manner in mouse brain. DH376 shows picomolar activity. | |||
TP1710 |
Calmodulin Binding Peptide 1
|
||
Calmodulin Binding Peptide 1, a potent CaM-binding peptide with picomolar (pM) affinity, originates from smooth muscle myosin light-chain kinase (MLCK peptide). It effectively blocks inositol trisphosphate (IP3)-induced calcium (Ca2+) release [1]. | |||
T12780 |
RP-001
|
Others | Others |
RP-001 is a selective agonist of picomolar short-acting S1P1 (EDG1)(EC50 of 9 pM), has little activity on S1P2-S1P4 and only moderate affinity for S1P5. | |||
T69885 | RK-52 | ||
RK-52 is a synthetic inhibitor of rhodesain, characterized by an impressive ksecond value (ksecond = 67000 × 103 M−1 min−1) and by a picomolar affinity toward the trypanosomal protease (Ki = 38 pM). | |||
T69009 |
Gnidimacrin
|
||
Gnidimacrin activated HIV-1 replication and killed persistently-infected cells at picomolar concentrations. In addition to its potential to purge HIV-1 from latently infected cells, gnidimacrin potently inhibited a panel of HIV-1 R5 virus infection of peripheral blood mononuclear cells (PBMCs) at an average concentration lower than 10 pM. These results suggest that gnidimacrin could activate latent HIV-1, specifically kill HIV-1 persistently infected cells, and inhibit R5 viruses at picomolar c... | |||
T11688 |
ITI-214 free base
ITI214 free base |
Others | Others |
ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and ion channels, exhibits potent PDE1 inhibitory activity (Ki = 58 pM). | |||
T30535 |
BMS-639623
UNII-PON9OFP69G,PON9OFP69G,BMS 639623,CHEMBL399495 |
||
BMS-639623 is a CCR3 antagonist with a picomolar inhibitory effect on eosinophilic chemotaxis and can be used in the treatment of asthma. | |||
T12780L |
RP-001 hydrochloride
|
Others | Others |
RP-001 hydrochloride is a selective agonist of picomolar short-acting S1P1 (EDG1)(EC50 of 9 pM), has little activity on S1P2-S1P4 and only moderate affinity for S1P5. | |||
T82957 |
ASN 07115873
|
||
ASN 07115873为具有显著抗ZIKV活性的化合物,其半抑制浓度(IC50)为189.2 pM,适用于抗病毒研究领域。 | |||
T11441 |
GNE-987
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
GNE-987 is a highly active chimeric BET degrader. GNE-987 binds equipotently to the BD1 and BD2 bromodomains of BRD4 with low nanomolar affinities (IC50: 4.7 and 4.4 nM, respectively). GNE-987 exhibits picomolar cell BRD4 degradation activity (DC50: 0.03 | |||
T80593 |
Brolucizumab
DLX1008,ESBA 1008,RTH258 |
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Brolucizumab(DLX1008)是一种具有高亲和力(KD=1.05 pM)的单链抗VEGF-A抗体片段,适用于癌症研究。 | |||
T78249 |
Nipocalimab
M281 |
||
Nipocalimab (M281)为全人源重组非糖基化IgG1型单克隆抗体。该抗体作为去糖基化IgG1对抗FcRn,能够在体内pH 6.0与胞外pH 7.6的条件下,以皮摩尔级别的亲和力与Fc受体(FcRn)结合。 | |||
T69675 |
PSB-1901 free base
|
||
PSB-1901 is a potent A2B Adenosine Receptor Antagonist with Picomolar Potency (Ki 0.0835 nM, KB 0.0598 nM, human A2BAR) with >10 000-fold selectivity versus all other AR subtypes. PSB-1901 was similarly potent and selective at the mouse A2BAR, making it a promising tool for preclinical studies. | |||
T35888 |
PB1
|
||
PB1 is a highly-effective intracellular disulfide reducing agent with notable attributes such as excellent cell permeability, the capacity to generate a substantial intracellular concentration gradient, and remarkable stability. It serves as a borane-protected TCEP (tris(2-carboxyethyl)phosphine) analogue. PB1 demonstrates the potential to enhance the survival of retinal ganglion cells following axotomy in vitro at concentrations in the nanomolar and picomolar range. Consequently, PB1 has proven... | |||
T35889 |
PB2
|
||
PB2, a tris(2-carboxyethyl)phosphine (TCEP) analogue, enhances the survival of retinal ganglion cells (RGCs) following axotomy in vitro. Even at nanomolar and picomolar concentrations, PB2 demonstrates pronounced efficacy in promoting RGC survival. Notably, PB2 exhibits superior permeability compared to TCEP. Serving as a potent reducing agent, PB2 provides robust neuroprotection for RGCs[1]. | |||
T79141 |
Mosnodenvir
JNJ-1802 |
Virus Protease | Microbiology/Virology |
Mosnodenvir(JNJ-1802)是一种泛血清型登革热抗病毒药物,表现出较高的耐药性屏障,同时安全性和耐受性均优良。它通过阻断NS3-NS4B相互作用来抑制病毒复制复合体。在小鼠模型中,Mosnodenvir展示了从皮摩尔到低纳摩尔量级的体外抗病毒效能。 | |||
T69596 |
SK-575
|
||
SK-575 is a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers. SK-575 potently inhibits the growth of cancer cells bearing BRCA1/2 mutations and induces potent and specific degradation of PARP1 in various human cancer cells even at low picomolar concentrations. SK-575 achieves durable tumor growth inhibition in mice when used as a single agent or in combination with cytotoxic agents, such as temozolomide and cisplatin. | |||
T80959 |
Trabikibart
CSL311 |
||
Trabikibart(CSL311)为βc特异性的全人源单克隆抗体,专一性结合人βc受体的细胞因子结合位点表位,并展现高皮摩尔级别的结合亲和力。此抗体能有效抑制IL-3、GM-CSF和IL-5在嗜酸性粒细胞存活中的协同作用,显示出治疗慢性炎症性疾病的应用潜力。 | |||
TP1532 |
γ-2-MSH (41-58), amide
|
||
Melanocortin (MC) 3-MSH (Melanocyte-Stimulating Hormone) is believed to signal through the MC 3 receptor. It induces a sustained increase in intracellular free calcium levels ([Ca2+]i) in a subpopulation of pituitary cells. Most of the cells responding to |